Dr. Cynthia X. Qian shares an in-depth overview of Retinitis Pigmentosa, highlighting potential treatment approaches at various stages of disease progression. Dr. Qian further describes the first approved gene therapy for a specific type of Retinitis Pigmentosa and how this therapy sets the stage for targeted gene therapies for various inherited retinal dystrophies in the near future. For more information on the guest, check out our website: http://broadeye.org/cynthia-qian/ Listen on Spotify: https://spoti.fi/31XqFak Listen on Google Podcasts: https://bit.ly/30qrtUr Listen on Apple Podcasts: https://apple.co/3ouneQh Follow us on Social Media: Facebook: / broadeyepodcast LinkedIn: / broa. . Twitter: / broadeyepodcast